Hemodiafiltration with endogenous reinfusion for uremic toxin removal in patients undergoing maintenance hemodialysis: a pilot study
Objective To delineate the efficacy and safety profile of hemodiafiltration with endogenous reinfusion (HFR) for uremic toxin removal in patients undergoing maintenance hemodialysis (MHD).Methods Patients who have been on MHD for a period of at least 3 months were enrolled. Each subject underwent on...
Saved in:
Main Authors: | Renhua Lu, Yan Fang, Wangshu Wu, Xiaojun Zeng, Tingting Liu, Yue Qian, Yuanyuan Xie, Yijun Zhou, Leyi Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2338929 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolomics to Identify Unclassified Uremic Toxins: A Comprehensive Literature Review
by: Raymond Vanholder, et al.
Published: (2025-03-01) -
Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease
by: M. O. Pyatchenkov, et al.
Published: (2023-09-01) -
Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01) -
Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders
by: Shihan Zhang, et al.
Published: (2025-01-01) -
Effect of intermittent infusion hemodiafiltration on cerebral and hepatic oxygenation
by: Susumu Ookawara, et al.
Published: (2025-01-01)